Biomarkers: Their potential in the diagnosis and treatment of heart failure.

@article{Heil2015BiomarkersTP,
  title={Biomarkers: Their potential in the diagnosis and treatment of heart failure.},
  author={Barbara Heil and W H Wilson Tang},
  journal={Cleveland Clinic journal of medicine},
  year={2015},
  volume={82 12 Suppl 2},
  pages={
          S28-35
        }
}
The increasing use of cardiac biomarkers in the diagnosis and management of heart failure (HF) has led to their inclusion in clinical practice guidelines. Studies have demonstrated that natriuretic peptides and cardiac troponins are useful adjuncts in identifying patients with HF at high risk, and we now know that a number of factors influence biomarker levels, including age, renal failure, obesity, and comorbid conditions, and that these factors as well as biomarker assay variability need to… CONTINUE READING
1
Twitter Mention

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury.

  • Circulation research
  • 2017
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure.

Junjie Xiao, Rongrong Gao, +13 authors Saumya Das
  • Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
  • 2017

References

Publications referenced by this paper.
SHOWING 1-10 OF 65 REFERENCES